Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation

Cancer Research

Volumn 64, Issue 12, 2004, Pages 4162-4170

  Kirma, Nameer ^a,b   Luthra, Roopa ^a,b   Jones, Jeremy ^a   Liu, Ya Guang ^a   Nair, Hareesh B ^a   Mandava, Usha ^a,c   Tekmal, Rajeshwar Rao ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C FMS RECEPTOR; COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; CYCLINE; DIMETHYLBENZ[A]ANTHRACENE; ESTROGEN RECEPTOR ALPHA; PROGESTERONE RECEPTOR; PROTEIN C JUN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST DYSPLASIA; BREAST HYPERPLASIA; BREAST TUMOR; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; LACTATION; MAMMARY GLAND; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENIC MOUSE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; HYPERPLASIA; MACROPHAGE COLONY-STIMULATING FACTOR; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR;

EID: 3042523489     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2971     Document Type: Article

References (17)

1. McGuire WL. An update on estrogen and progesterone receptors in primary and advanced cancer. In: Iacobeli R, King B, Linder HR, Lipman ME, editors. Hormones and cancer. New York: Raven Press; 1980. p. 337-44.
2. Saunderland MC, McGuire WL. Oncogenes as clinical prognostic indicators. In: Lipman ME, Dikson R, editors. Regulatory mechanisms of breast cancer: advances in cellular and molecular biology of breast cancer. Boston: Kluwer Academic Publishers; 1990, p. 3-22.
3. Harris JR, Lippman ME, Veronesi U, Willett W. Breast cancer (1). N Engl J Med 1992;327:319-28.
4. Baiocchi G, Kavanagh JJ, Talpaz M, Wharton JT, Gutterman JU, Kurzrock R. Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies. Cancer (Phila) 1991;67:990-6.
5. Sapi E, Kacinski BM. The role of CSF-1 in normal and neoplastic breast physiology. Proc Soc Exp Biol Med 1999;220:1-8.
6. Lin EY, Gouon-Evans V, Nguyen AV, Pollard JW. The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia 2002;7:147-62.
7. Tekmal RR, Ramachandra N, Gubba S, et al. Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities. Cancer Res 1996;56:3180-5.
8. Kirma N, Gill K, Mandava U, Tekmal RR. Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice. Cancer Res 2001;61:1910-8.
9. Medina D. Mammary tumors. In: Foster H, Small, JD, Fox, JG, editors. The mouse in biomedical research, Vol. 4. New York: Academic Press; 1982. p. 373-96.
10. Schneider W, Ramachandran C, Satyaswaroop PG, Shyamala G. Murine progesterone receptor exists predominantly as the 83-kilodalton 'A' form. J Steroid Biochem Mol Biol 1991;38:285-91.
11. Dey A, She H, Kim L, et al. Colony-stimulating factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2 expression. Mol Biol Cell 2000;11: 3835-48.
12. Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001;193:727-40.
13. Stanley ER, Berg KL, Einstein DB, et al. Biology and action of colony-stimulating factor-1. Mol Reprod Dev 1997;46:4-10.
14. Keshava N, Mandava U, Kirma N, Tekmal RR. Acceleration of mammary neoplasia in aromatase transgenic mice by 7,12-dimethylbenz[a]anthracene. Cancer Lett 2001; 167:125-33.
15. Shyamala G. Progesterone signaling and mammary gland morphogenesis. J Mammary Gland Biol Neoplasia 1999;4:89-104.
16. Lyman SD, Williams DE. Biology and potential clinical applications of flt3 ligand. Curr Opin Hematol 1995;2:177-81.
17. Shyamala G, Yang X, Cardiff RD, Dale E. Impact of progesterone receptor on cell-fate decisions during mammary gland development. Proc Natl Acad Sci USA 2000;97:3044-9.